Data items collected include date of castrate resistance, start and stop dates for all PCa treatments and results of imaging and laboratory tests (e.g., PSA kinetics, skeletal events and assessment of Eastern Cooperative Oncology Group (ECOG) performance status [25]). Here, KLK3 is linked to posterior cortical atrophy.